An analysis of data from the FAME trials was undertaken to try to understand the final three-year visual and anatomic outcomes of patients treated with the fluocinolone acetonide intravitreal implant (Iluvien, Alimera Sciences) who exhibi
Recent years have brought major changes to the recommendations on screening patients for chloroquine and hydroxychloroquine (HCQ) retinopathy.
Retinal vein occlusions (RVOs) are a frequent cause of retinal vascular disease in patients older than 50 years.
Reviewed by James Philip Dunn Jr., MD
An open-label extension of two pivotal clinical trials has given ophthalmologists critical, real-world evidence of the effectiveness of adalimumab as a treatment of noninfectious intermediate uveitis.
Optical coherence tomography angiography (OCTA) could play a growing role in the assessment of anterior inflammation from uveitis, according to results from a pilot study presented by Francesco Pichi, MD.
With advances in local treatment of uveitis over the past decade, the therapeutic armamentarium has increased from depot injections with short-lasting activity to long-term treatments, said Thomas A. Albini, MD.
An analysis of data from the Intelligent Research in Sight (IRIS) Registry provides insights about real-world success rates for primary repair of retinal detachments, said Richard S. Kaiser, MD.
An intravitreal injection device can provide repeatable results and added comfort for the patient, removing the need for a drape and speculum.